Product Portfolio

Overview

Your hands are sophisticated tools; they deserve sophisticated sutures

We understand that ‘one size does not fit all’ when it comes to sutures.

When choosing the perfect suture, as surgeons you need to consider possible complications, tissue type, expected holding power of the tissue and the need for long‑term approximation.

As pioneers in suture development, Medtronic appreciates these considerations, and provides innovative tools to address individual patient needs.

A full range of options

Our range of absorbable sutures is both versatile and unparalleled, offering short-, mid- and long-term wound support: 

  • Short-term5 – Caprosyn™ 
  • Mid-term11 – Biosyn™  
  • Long-term13 – Maxon™  

Monofilament absorbable sutures:

 

Tensile strength

Mass absorption (days)

Caprosyn5

20–30% at 10 days

56

Biosyn10

40% at 21 days

90–110

Maxon13

25% at 42 days

180–210


With braided and unbraided options, the range not only provides effective wound closure solutions for both surgeon and patient, but also offers innovative sutures to cater for your specific surgical requirements.

Absorbable sutures designed for all applications

Our extensive absorbable suture range suits a diverse range of wound closures, including plastic surgery,15 gynaecology,16 general surgery17 plus many more.

  • ™* Third party brands are trademarks of their respective owners.

  • 1. Velosorb™ Instructions for Use.

  • 2. Covidien R&D. FAB-006 Product Performance Testing Lab #2. 19 January 2012.

  • 3. FAB-005 Sam Yang Data Sterilized In-Vitro Report - 4/20/2012.

  • 4. FAB-002 Rapide Data Report.

  • 5. Caprosyn™ Instructions for Use.

  • 6. Based on internal research and development, tensile strength size 2/0, kg of force.  

  • 7. Drake DB, Rodeheaver PF, Edlich RF, Rodeheaver GT. Experimental studies in swine for measurement of suture extrusion. J Long Term Eff Med Implants. 2004;14:251–259. 

  • 8. Polysorb™ Instructions for Use.  

  • 9. Green CW, Beltran KA, Faulkner BC et al. A Comparative Performance Evaluation - L16 VI. March 6, 1996.

  • 10. Biosyn™ Instructions for Use.

  • 11. Rodeheaver GT, Beltran KA, Green CW et al. Biomechanical Clinical Performance of a New Synthetic Monofilament Absorbable Suture. J Long-Term Eff Med. 1996;6:181–198.

  • 12. Stopek JB, Migliozzi J, Chai C et al. Bacterial Colonization of Suture Biomaterials with Varied Substrate Architecture and Chemistry, Covidien sponsored study. 32nd Annual Meeting of the Society for Biomaterials, 18–21 April 2007. Chicago, IL, US.

  • 13. Maxon™ Instructions for Use.

  • 14. Fong ED, Bartlett ASR, Malak S et al. Tensile strength of surgical knots in abdominal wound closure. ANZ J Surg. 2008;78:164–166.

  • 15. de Blacam C, Colakoglu S, Momoh AO et al. Early Experience With Barbed Sutures for Abdominal Closure in Deep Inferior Epigastric Perforator Flap Breast Reconstruction. Presented at the New England Society of Plastic and Reconstructive Surgeons Meeting, Brewster, MA, US, June 2011. Eplasty. 2012;12:e24.

  • 16. Alessandri F, Remorgida V, Venturini PL et al. Unidirectional barbed suture versus continuous suture with intracorporeal knots in laparoscopic myomectomy: a randomized study. J Minim Invasive Gynecol. 2011;17:725–729.

  • 17. Capla JM, Dunn RM, Gusenoff J et al. A prospective, randomized study to evaluate dermal closure with an absorbable barbed suture (V-Loc™ 90 device or V-Loc™ 180 device) as compared to a conventional absorbable suture. Am Coll Surg. 2011;S94.